Rabivax is a freeze-dried, purified rabies vaccine for human use, supplied with a diluent for reconstitution. It provides active immunization against the rabies virus and is indicated for both pre-exposure prophylaxis and post-exposure prophylaxis following animal bites or scratches.

**Key Features & Applications**

* **Active Immunization:** Induces strong protective antibody titers against the rabies virus.
* **Dual Protection Protocols:**
* **Post-Exposure Prophylaxis (PEP):** Essential for individuals exposed to potentially rabid animals (bites, scratches, or mucosa exposure).
* **Pre-Exposure Prophylaxis (PrEP):** Recommended for high-risk individuals, including veterinarians, animal handlers, field researchers, and laboratory personnel.


* **High Purity & Quality:** Formulated under strict pharmaceutical standards to ensure optimum potency and safety.

**Administration & Dosage**

* **Volume:** 1 ml reconstituted suspension per dose.
* **Route of Administration:** Intramuscular (IM) injection, typically in the deltoid region for adults and older children, or anterolateral thigh in infants. *(Do not administer gluteally).*
* **Schedule:** Must be administered according to standard WHO-approved post-exposure or pre-exposure regimens under strict clinical supervision.

**Storage Instructions**

* Store refrigerated between 2°C to 8°C (36°F to 46°F).
* Protect from light. Do not freeze. Reconstitute immediately before administration.

**Precautions**

* For human use only.
* Must be prescribed and administered under the supervision of a certified healthcare professional.
* For severe post-exposure cases (Category III), Rabies Immunoglobulin (RIG) may be required in conjunction with the initial vaccine dose.